Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Health Economics and Management Sciences, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
BMC Health Serv Res. 2023 Mar 14;23(1):251. doi: 10.1186/s12913-023-09229-6.
Since the start of the AIDS outbreak, the human immunodeficiency virus (HIV) has infected about 84.2 million people, and approximately 40.1 million people have died due to AIDS-related diseases. So, this study aims to provide a comprehensive population-based description of patient costs and the economic burden of HIV/AIDS in Iran.
The study population of this cross-sectional cost-of-illness study consisted of HIV-infected patients who were receiving services in Mashhad and were under the supervision of BIDCC. There are four BIDCC centers in Mashhad, we considered all patients referred to these centers. Costs data were evaluated from a social perspective with a bottom-up approach and as a prevalence based. The data from 157 individuals were included in the study. For collecting data on direct and indirect costs belonging to patients and their families, a questionnaire was developed. Also, the Demographic characteristic of participants and the stage of the disease and Transmission category were analyzed.
In this study, 57.32 of the subjects were Male. The majority of participants in this study were in the age group 30-59 years (n = 124,78.98%). Based on where the patients live, the majority of patients have lived in the urban region (n = 144, 91.72%). The most common way to transmit this disease is through unprotected sex (30.57%) and then Infected spouse (28.03%), and then injecting drugs (21.02%). The highest cost of this disease is attributed to medicine (10339.32 $ for 6 months), after medicine, the cost of tests was 9101.22 $.
It seems that to reduce costs for patients with disease HIV/AIDS, the focus should be on diagnostic tests and care. Early diagnosis and rapid initiation of antiviral treatments can be effective in preventing serious and debilitating diseases.
自艾滋病疫情爆发以来，人类免疫缺陷病毒（HIV）已感染约 8420 万人，约 4010 万人死于艾滋病相关疾病。因此，本研究旨在全面描述伊朗艾滋病毒/艾滋病患者的费用和经济负担。
本病例对照研究的研究人群包括在马什哈德接受服务并由 BIDCC 监督的 HIV 感染者。马什哈德有四个 BIDCC 中心，我们考虑了所有转介到这些中心的患者。从社会角度，采用自下而上的方法和基于患病率的方法评估成本数据。通过开发问卷，从患者及其家庭的角度评估了直接和间接成本数据。此外，还分析了参与者的人口统计学特征、疾病阶段和传播类别。
在这项研究中，57.32%的参与者为男性。大多数参与者的年龄在 30-59 岁之间（n=124，78.98%）。根据患者居住地，大多数患者居住在城市地区（n=144，91.72%）。这种疾病最常见的传播途径是无保护性行为（30.57%），其次是受感染的配偶（28.03%），然后是静脉注射毒品（21.02%）。这种疾病的最高费用归因于药物（6 个月 10339.32 美元），其次是药物，测试费用为 9101.22 美元。
似乎为了降低 HIV/AIDS 患者的费用，重点应放在诊断测试和护理上。早期诊断和快速启动抗病毒治疗可以有效预防严重和致残疾病。
